GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abnova (Taiwan) Corp (TPE:4133) » Definitions » Cyclically Adjusted Price-to-FCF

Abnova (Taiwan) (TPE:4133) Cyclically Adjusted Price-to-FCF : 50.73 (As of Jun. 05, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Abnova (Taiwan) Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Abnova (Taiwan)'s current share price is NT$31.45. Abnova (Taiwan)'s Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was NT$0.62. Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF for today is 50.73.

The historical rank and industry rank for Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TPE:4133' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 38.39   Med: 51.76   Max: 260.34
Current: 49.09

During the past years, Abnova (Taiwan)'s highest Cyclically Adjusted Price-to-FCF was 260.34. The lowest was 38.39. And the median was 51.76.

TPE:4133's Cyclically Adjusted Price-to-FCF is ranked worse than
50.49% of 103 companies
in the Biotechnology industry
Industry Median: 49.09 vs TPE:4133: 49.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abnova (Taiwan)'s adjusted free cash flow per share data for the three months ended in Mar. 2025 was NT$-0.111. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is NT$0.62 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abnova (Taiwan) Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abnova (Taiwan) Cyclically Adjusted Price-to-FCF Chart

Abnova (Taiwan) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.80 76.32 55.58 51.18 48.17

Abnova (Taiwan) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.39 46.29 44.73 48.17 45.40

Competitive Comparison of Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF falls into.


;
;

Abnova (Taiwan) Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=31.45/0.62
=50.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abnova (Taiwan)'s Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Abnova (Taiwan)'s adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.111/134.9266*134.9266
=-0.111

Current CPI (Mar. 2025) = 134.9266.

Abnova (Taiwan) Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.301 100.684 0.403
201509 -2.185 100.392 -2.937
201512 0.376 99.792 0.508
201603 -0.034 100.470 -0.046
201606 0.125 101.688 0.166
201609 0.118 101.861 0.156
201612 -0.324 101.863 -0.429
201703 -0.165 102.862 -0.216
201706 -0.256 103.349 -0.334
201709 0.087 104.136 0.113
201712 -0.002 104.011 -0.003
201803 -0.955 105.290 -1.224
201806 -0.040 106.317 -0.051
201809 0.317 106.507 0.402
201812 0.755 105.998 0.961
201903 0.068 107.251 0.086
201906 0.303 108.070 0.378
201909 0.452 108.329 0.563
201912 0.223 108.420 0.278
202003 0.026 108.902 0.032
202006 0.424 108.767 0.526
202009 0.676 109.815 0.831
202012 0.504 109.897 0.619
202103 0.153 111.754 0.185
202106 0.523 114.631 0.616
202109 0.497 115.734 0.579
202112 0.334 117.630 0.383
202203 0.467 121.301 0.519
202206 0.546 125.017 0.589
202209 0.828 125.227 0.892
202212 0.229 125.222 0.247
202303 0.360 127.348 0.381
202306 0.615 128.729 0.645
202309 0.003 129.860 0.003
202312 -0.193 129.419 -0.201
202403 0.115 131.776 0.118
202406 0.658 132.554 0.670
202409 -0.122 133.029 -0.124
202412 0.059 133.157 0.060
202503 -0.111 134.927 -0.111

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abnova (Taiwan)  (TPE:4133) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Abnova (Taiwan) Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Abnova (Taiwan)'s Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abnova (Taiwan) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No.108, Jhouzih Street, 9th Floor, Neihu District, Taipei City, TWN
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries.

Abnova (Taiwan) Headlines

No Headlines